Regeneron Pharmaceuticals Inc. (REGN)

Regeneron Pharmaceuticals Inc. (REGN $589.48)
- $589.48 P/E (TTM): 15.05X Cap: $62.47B
- View REGN Profile
- View Questions on REGN

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Regeneron Pharmaceuticals Inc. (REGN $589.48)
- $589.48 P/E (TTM): 15.05X Cap: $62.47B
- View REGN Profile
- View Questions on REGN

Q: Please give us your best guess as to what is happening with REGN. Everything looks okay for a hold but the market seems to disagree with JP Morgan who has a 800$ target (almost 50% upside). Opportunity or falling knife?

Thanks to you and o all the members for excellent questions and contribution

Read Answer Asked by Jean on July 17, 2025

Apple Inc. (AAPL $227.76)
- $227.76 P/E (TTM): 34.13X Cap: $3.38T
- View AAPL Profile
- View Questions on AAPL
Regeneron Pharmaceuticals Inc. (REGN $589.48)
- $589.48 P/E (TTM): 15.05X Cap: $62.47B
- View REGN Profile
- View Questions on REGN
UnitedHealth Group Incorporated (DE) (UNH $307.42)
- $307.42 P/E (TTM): 12.7X Cap: $278.42B
- View UNH Profile
- View Questions on UNH
Canadian Natural Resources Limited (CNQ $43.07)
- $43.07 P/E (TTM): 10.64X Cap: $89.96B
- View CNQ Profile
- View Questions on CNQ
Sun Life Financial Inc. (SLF $81.49)
- $81.49 P/E (TTM): 14.93X Cap: $46.31B
- View SLF Profile
- View Questions on SLF
- View Reports on SLF
CGI Inc. Class A Subordinate Voting Shares (GIB.A $134.08)
- $134.08 P/E (TTM): 17.41X Cap: $30.08B
- View GIB.A Profile
- View Questions on GIB.A
- View Reports on GIB.A
TFI International Inc. (TFII $133.86)
- $133.86 P/E (TTM): 21.23X Cap: $11.11B
- View TFII Profile
- View Questions on TFII
- View Reports on TFII
Alimentation Couche-Tard Inc. (ATD $69.70)
- $69.70 P/E (TTM): 18.77X Cap: $66.08B
- View ATD Profile
- View Questions on ATD
AAON Inc. (AAON $85.98)
- $85.98 P/E (TTM): 54.68X Cap: $6.52B
- View AAON Profile
- View Questions on AAON

Q: Sir: What 2 US and Canadian stocks or ETFs do you see most unfairly punished now, and most likely to reward , down the road. Also could you suggest one non US value ETF or stock that cheers you a lot? Thanks-JP

Read Answer Asked by James on July 11, 2025

Amgen Inc. (AMGN $293.72)
- $293.72 P/E (TTM): 24.16X Cap: $158.12B
- View AMGN Profile
- View Questions on AMGN
Regeneron Pharmaceuticals Inc. (REGN $589.48)
- $589.48 P/E (TTM): 15.05X Cap: $62.47B
- View REGN Profile
- View Questions on REGN

Q: Hi,
Could I please have you take on the stock performance of Regeneron Pharmaceuticals over the last year or so and its future prospects?
Thank you, Michael

Read Answer Asked by Michael on December 02, 2024